Results 101 to 110 of about 18,344 (221)

The once-daily fixed-dose combination of olodaterol and tiotropium in the management of COPD : current evidence and future prospects [PDF]

, 2019
Long-acting bronchodilators are the cornerstone of pharmacologic treatment of chronic obstructive pulmonary disease (COPD). Spiolto (R) or Stiolto (R) is a fixed-dose combination (FDC) containing two long-acting bronchodilators, the long-acting ...
Brusselle, Guy, Derom, Eric, Joos, Guy
core   +1 more source

Nanoparticles in the treatment of chronic lung diseases [PDF]

, 2019
Nanoparticles, although considered a topic of modern medicine, actually have an interesting history. Currently, advances in nanomedicine hold great promise as drug carrier systems for sustained release and targeted delivery of diverse therapeutic agents.
Alexescu, Teodora G, Cosnarovici, Maria, Negrean, Vasile, Orasan, Olga H, Para, Ioana, Perne, Mirela G, Popovici, Ionela, Ruta, Victoria M, Tarmure, Simina, Todea, Doina A   +9 more
core   +2 more sources

The efficacy of aclidinium/formoterol on lung function and symptoms in patients with COPD categorized by symptom status: a pooled analysis

International Journal of COPD, 2016
Marc Miravitlles,1 Kenneth R Chapman,2 Ferran Chuecos,3 Anna Ribera,4 Esther Garcia Gil3 1Department of Pneumology, Vall d’Hebron University Hospital, CIBER de Enfermedades Respiratorias (CIBERES), Barcelona, Spain; 2Asthma & Airway Centre ...
Miravitlles M, Chapman KR, Chuecos F, Ribera A, Garcia Gil E   +4 more
doaj  

β2-adrenoceptor-induced modulation of transglutaminase 2 transamidase activity in cardiomyoblasts [PDF]

, 2017
Tissue transglutaminase 2 (TG2) is modulated by protein kinase A (PKA) mediated phosphorylation: however, the precise mechanism(s) of its modulation by G-protein coupled receptors coupled to PKA activation are not fully understood.
Agnihotri, Alan J. Hargreaves, Alcock, Almami, Arcaro, Benovic, Boros, Caccamo, Camps, Carl P. Nelson, Cordella-Miele, Csósz, Daaka, David J. Boocock, de Wit, Donato, Dudley, Eckert, Falguni S. Vyas, Fiona Freeman, Freund, Gillet, Gundemir, Hescheler, Huang, Hunter, Hwang, Iismaa, Iwai, John M. Dickenson, Kase, Kimes, Király, Lambert, Lee, Lilley, Makitie, Mishra, Mishra, Naga Prasad, Nanda, Nurminskaya, Okamoto, Perry, Rajagopal, Rockman, Schaertl, Schmitt, Shin, Singh, Singh, Slaughter, Small, Smith, Steinberg, Szondy, Trigwell, Vlahos, Vyas, Wang, Yanagawa, Yano, Yu, Zamah, Zhang, Zhang   +65 more
core   +1 more source

Debate on long-acting β agonists for asthma:they think it's all over [PDF]

, 2017
At last, we can apparently relax in the secure knowledge that long-acting β agonists (LABA) are safe to use in persistent asthma when given in combination with inhaled corticosteroid (ICS), on the basis of the US Food and Drug Administration-mandated ...
Bleecker, Drake, Lee, Lipworth, Lipworth, Pauwels, Peters, Stempel, Tan, Thanawala, Thomas, Turner   +11 more
core   +2 more sources

Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes

Patient Related Outcome Measures, 2011
Richard D O'ConnorSharp Rees-Stealy Medical Group, San Diego, CA, USAAbstract: In the United States, budesonide/formoterol pressurized metered-dose inhaler (pMDI) is approved for treatment of asthma in patients aged ≥12 years whose asthma ...
Richard D O'Connor
doaj  

The effects of denervation and formoterol administration on facial growth

Australasian Orthodontic Journal, 2014
Objective: To identify and demonstrate possible alterations of skeletal structures which might follow either unilateral surgical denervation of the masseter muscle, unilateral intramuscular injection of formoterol directly into the masseter muscle, or ...
Fitzpatrick Brendan, Woods Michael, Lynch Gordon, Manton David   +3 more
doaj   +1 more source

Role of inhaled corticosteroids/formoterol in relieving acute asthma as compared to traditional salbutamol in children 6 to 11 years old on maintenance and reliever therapy step 3 and above as per the Global Initiative for Asthma guideline

Monaldi Archives for Chest Disease
The recent Global Initiative for Asthma (GINA) guidelines offer two reliever therapy options for patients on step 3 and above: the more popularly used short-acting β-agonists (SABA) and the newly introduced inhaled corticosteroids (ICS)-formoterol ...
Danish Abdul Aziz, Werdah Viquar
doaj   +1 more source

SIMVASTATIN INDUCED HISTOMORPHOLOGICAL CHANGES IN SKELETAL MUSCLE FIBER OF RATS AND PROTECTIVE EFFECT OF FORMOTEROL COADMINISTRATION

Pakistan Armed Forces Medical Journal, 2019
Objective: To study Simvastatin induced, qualitative histomorphological changes in skeletal muscle fibers of rats and find protective effect of Formoterol co-administration in Simvastatin induced myopathy.
Abdullah Qamar, Shoaib Naiyar Hashmi, Fareeha Mushtaq   +2 more
doaj  

EFFECT OF LONG ACTING β2-AGONISTS ON GROSS MORPHOLOGY OF SKELETAL MUSCLES AND CREATINE PHOSPHOKINASE LEVEL IN SIMVASTATIN INDUCED MYOPATHIES IN RATS

Pakistan Armed Forces Medical Journal, 2019
Objective: To study the gross morphology of skeletal muscles and plasma Creatinine phosphokinase levels of rats and find effect of long acting β2-agonists co-administration in Statin induced myopathies. Study Design: Quasi experimental study. Place
Abdullah Qamar, Hina Kundi, Maria Yousaf, Sajid Ali   +3 more
doaj